Skip to main content
Erschienen in: Herz 3/2015

01.05.2015 | e-Herz: Original article

Association between serum total antioxidant status and coronary microvascular function in idiopathic dilated cardiomyopathy

verfasst von: M. Caliskan, MD, H. Gullu, D. Erdogan, M. Ozulku, S. Kulaksızoglu, O. Ciftci, H. Muderrisoglu

Erschienen in: Herz | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Coronary microvascular impairment may cause myocardial ischemia and systolic dysfunction in patients with idiopathic dilated cardiomyopathy (IDC).

Patients and methods

The study included 41 patients with IDC and 33 healthy control subjects. Serum total antioxidant status (TAS), serum interleukin (IL)-6 levels, and tumor necrosis factor (TNF)-α levels were assayed and coronary flow reserve (CFR) was measured in all subjects via echocardiography.

Results

High-sensitivity C-reactive protein (hsCRP) levels were significantly higher in patients with IDC than in the control group (3.42 ± 2.14 vs. 1.91± 1.40, p = 0.001). Serum TAS was statistically lower in patients with IDC than in controls (1.23 ± 0.16 vs. 1.77 ± 0.12, p < 0.001). CFR was statistically and significantly lower in the IDC group (2.10 ± 0.39 vs. 3.09 ± 0.49, p < 0.001). The IDC group was subsequently subdivided into two groups according to CFR values, as CFR ≥ 2 and CFR < 2. HsCRP (4.30 ± 2.42 vs. 2.58 ± 1.42, p = 0.01), TNF-α (16.67 ± 8.08 vs. 10.97 ± 1.63, p = 0.01), and IL-6 (7.54 ± 6.16 vs. 3.14 ± 1.10, p = 0.05) values were significantly higher in the CFR < 2 group compared with the higher CFR group. TAS (1.3 ± 0.16 vs. 1.14 ± 0.10, p < 0.001) was significantly lower in the CFR < 2 group. CFR correlated significantly with hsCRP, TAS, red cell distribution width (RDW), IL-6, and TNF-α.

Conclusion

Plasma proinflammatory cytokine levels are increased in patients with IDC. CFR was impaired as a reflection of impaired coronary microvascular dysfunction in association with increasing plasma proinflammatory cytokine levels and hsCRP levels.
Literatur
1.
Zurück zum Zitat Vanderheyden M, Bartunek J, Verstreken S et al (2005) Non-invasive assessment of coronary flow reserve in idiopathic dilated cardiomyopathy: hemodynamic correlations. Eur J Echocardiogr 6:47–53CrossRefPubMed Vanderheyden M, Bartunek J, Verstreken S et al (2005) Non-invasive assessment of coronary flow reserve in idiopathic dilated cardiomyopathy: hemodynamic correlations. Eur J Echocardiogr 6:47–53CrossRefPubMed
2.
Zurück zum Zitat Calişkan M, Ciftçi O, Güllü H, Müderrisoğlu H (2008) The effect of carvedilol therapy on coronary flow reserve in patients with idiopathic dilated cardiomyopathy. Turk Kardiyol Dern Ars 36(4):247–252PubMed Calişkan M, Ciftçi O, Güllü H, Müderrisoğlu H (2008) The effect of carvedilol therapy on coronary flow reserve in patients with idiopathic dilated cardiomyopathy. Turk Kardiyol Dern Ars 36(4):247–252PubMed
3.
Zurück zum Zitat Spinale FG, Tanaka R, Crawford FA, Zile MR (1992) Changes in myocardial blood flow during development of and recovery from tachycardia-induced cardiomyopathy. Circulation 85:717–729CrossRefPubMed Spinale FG, Tanaka R, Crawford FA, Zile MR (1992) Changes in myocardial blood flow during development of and recovery from tachycardia-induced cardiomyopathy. Circulation 85:717–729CrossRefPubMed
4.
Zurück zum Zitat Sorensen KE, Celemar DS, Spiegelhalter DJ et al (1995) Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J 74:247–253CrossRefPubMedCentralPubMed Sorensen KE, Celemar DS, Spiegelhalter DJ et al (1995) Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J 74:247–253CrossRefPubMedCentralPubMed
5.
Zurück zum Zitat Dimitrow PP, Galderisi M, Rigo F (2005) The non-invasive documentation of coronary microcirculation impairment: role of transthoracic echocardiography. Cardiovasc Ultrasound 4:18CrossRef Dimitrow PP, Galderisi M, Rigo F (2005) The non-invasive documentation of coronary microcirculation impairment: role of transthoracic echocardiography. Cardiovasc Ultrasound 4:18CrossRef
6.
Zurück zum Zitat Mann DL, Young JB (1994) Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest 105:897–904CrossRefPubMed Mann DL, Young JB (1994) Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest 105:897–904CrossRefPubMed
7.
Zurück zum Zitat Aukrust P, Ueland T, Lien E et al (1999) Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 83:376–382CrossRefPubMed Aukrust P, Ueland T, Lien E et al (1999) Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 83:376–382CrossRefPubMed
8.
Zurück zum Zitat Satoh M, Nakamura M, Saitoh H et al (1999) Tumor necrosis factor-a-converting enzyme and tumor necrosis factor-a in human dilated cardiomyopathy. Circulation 99:3260–3265CrossRefPubMed Satoh M, Nakamura M, Saitoh H et al (1999) Tumor necrosis factor-a-converting enzyme and tumor necrosis factor-a in human dilated cardiomyopathy. Circulation 99:3260–3265CrossRefPubMed
9.
Zurück zum Zitat Kubota T, Miyagishima M, Alvarez M et al (2000) Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-staged congestive heart failure. J Heart Lung Transplant 19:819–824CrossRefPubMed Kubota T, Miyagishima M, Alvarez M et al (2000) Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-staged congestive heart failure. J Heart Lung Transplant 19:819–824CrossRefPubMed
10.
Zurück zum Zitat Torre-Amione G, Stetson SJ, Youker KA et al (1999) Decreased expression of tumor necrosis factor-a in failing human myocardium after mechanical circulatory support: a potential mechanism for cardiac recovery. Circulation 100:1189–1193CrossRefPubMed Torre-Amione G, Stetson SJ, Youker KA et al (1999) Decreased expression of tumor necrosis factor-a in failing human myocardium after mechanical circulatory support: a potential mechanism for cardiac recovery. Circulation 100:1189–1193CrossRefPubMed
11.
Zurück zum Zitat Tsutamoto T, Hisanaga T, Wada A et al (1998) Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 31:391–398CrossRefPubMed Tsutamoto T, Hisanaga T, Wada A et al (1998) Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 31:391–398CrossRefPubMed
12.
Zurück zum Zitat De Zwart LL, Meerman JH, Commandeur JN, Vermeulen NP (1999) Biomarkers of free radical damage applications in experimental animals and in humans. Free Radic Biol Med 26:202CrossRef De Zwart LL, Meerman JH, Commandeur JN, Vermeulen NP (1999) Biomarkers of free radical damage applications in experimental animals and in humans. Free Radic Biol Med 26:202CrossRef
13.
Zurück zum Zitat Siemianowicz K, Gminski J, Telega A et al (2004) Blood antioxidant parameters in patients with diabetic retinopathy. Int J Mol Med 14:433PubMed Siemianowicz K, Gminski J, Telega A et al (2004) Blood antioxidant parameters in patients with diabetic retinopathy. Int J Mol Med 14:433PubMed
14.
Zurück zum Zitat Kaski JP, Elliott P; ESC Working Group (2007) The classification concept of the ESC Working Group on myocardial and pericardial diseases for dilated cardiomyopathy. Herz 32:446–451CrossRefPubMed Kaski JP, Elliott P; ESC Working Group (2007) The classification concept of the ESC Working Group on myocardial and pericardial diseases for dilated cardiomyopathy. Herz 32:446–451CrossRefPubMed
15.
Zurück zum Zitat n a (1990) American Heart Association/American College of Cardiology ACC/AHA guidelines for the clinical application of echocardiography. Report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for the Clinical Application of Echocardiography). J Am Coll Cardiol 16:1505–1528CrossRef n a (1990) American Heart Association/American College of Cardiology ACC/AHA guidelines for the clinical application of echocardiography. Report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for the Clinical Application of Echocardiography). J Am Coll Cardiol 16:1505–1528CrossRef
16.
17.
Zurück zum Zitat Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE (2004) Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes 53:2079–2086CrossRefPubMed Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE (2004) Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes 53:2079–2086CrossRefPubMed
18.
Zurück zum Zitat Dimitrow PP (2003) Transthoracic Doppler echocardiography- noninvasive diagnostic window for coronary flow reserve assessment. Cardiovasc Ultrasound 11:4CrossRef Dimitrow PP (2003) Transthoracic Doppler echocardiography- noninvasive diagnostic window for coronary flow reserve assessment. Cardiovasc Ultrasound 11:4CrossRef
19.
Zurück zum Zitat Gullu H, Erdogan D, Caliskan M et al (2006) Interrelationship between noninvasive predictors of atherosclerosis: transthoracic coronary flow reserve, flow-mediated dilation, carotid intima-media thickness, aortic stiffness, aortic distensibility, elastic modulus, and brachial artery diameter. Echocardiography 23(10):835–842CrossRefPubMed Gullu H, Erdogan D, Caliskan M et al (2006) Interrelationship between noninvasive predictors of atherosclerosis: transthoracic coronary flow reserve, flow-mediated dilation, carotid intima-media thickness, aortic stiffness, aortic distensibility, elastic modulus, and brachial artery diameter. Echocardiography 23(10):835–842CrossRefPubMed
20.
Zurück zum Zitat Tentolouris C, Tousoulis D, Antoniades C et al (2004) Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy. Int J Cardiol 94(2–3):301–305 Tentolouris C, Tousoulis D, Antoniades C et al (2004) Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy. Int J Cardiol 94(2–3):301–305
21.
Zurück zum Zitat Tsutamoto T, Wada A, Ohnishi M et al (2004) Transcardiac increase in tumor necrosis factor-alpha and left ventricular end-diastolic volume in patients with dilated cardiomyopathy. Eur J Heart Fail 6(2):173–180CrossRefPubMed Tsutamoto T, Wada A, Ohnishi M et al (2004) Transcardiac increase in tumor necrosis factor-alpha and left ventricular end-diastolic volume in patients with dilated cardiomyopathy. Eur J Heart Fail 6(2):173–180CrossRefPubMed
22.
Zurück zum Zitat Patel SS, Thiagarajan R, Willerson JT, Yeh ETH (1998) Inhibition of a4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice. Circulation 97:75–81CrossRefPubMed Patel SS, Thiagarajan R, Willerson JT, Yeh ETH (1998) Inhibition of a4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice. Circulation 97:75–81CrossRefPubMed
23.
Zurück zum Zitat Yokoyama T, Vaca L, Rossen RD et al (1993) Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the mammalian heart. J Clin Invest 92:2303–2312CrossRefPubMedCentralPubMed Yokoyama T, Vaca L, Rossen RD et al (1993) Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the mammalian heart. J Clin Invest 92:2303–2312CrossRefPubMedCentralPubMed
24.
26.
Zurück zum Zitat Levine B, Kalman J, Mayer L et al (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323:236–241CrossRefPubMed Levine B, Kalman J, Mayer L et al (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323:236–241CrossRefPubMed
27.
Zurück zum Zitat Bryant D, Becker L, Richardson J et al (1998) Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-a. Circulation 97:1375–1381CrossRefPubMed Bryant D, Becker L, Richardson J et al (1998) Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-a. Circulation 97:1375–1381CrossRefPubMed
28.
Zurück zum Zitat Kubota T, McTierman CF, Frye CS et al (1997) Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-a. Circ Res 81:627–635CrossRefPubMed Kubota T, McTierman CF, Frye CS et al (1997) Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-a. Circ Res 81:627–635CrossRefPubMed
29.
Zurück zum Zitat Inoue T, Sakai Y, Morooka S et al (1993) Coronary flow reserve in patients with dilated cardiomyopathy. Am Heart J 125:93–98CrossRefPubMed Inoue T, Sakai Y, Morooka S et al (1993) Coronary flow reserve in patients with dilated cardiomyopathy. Am Heart J 125:93–98CrossRefPubMed
30.
Zurück zum Zitat Witztum JL (1994) The oxidation hypothesis of atherosclerosis. Lancer 344:793–795CrossRef Witztum JL (1994) The oxidation hypothesis of atherosclerosis. Lancer 344:793–795CrossRef
31.
Zurück zum Zitat Britten MB, Zeiher AM, Schächinger V (2004) Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome. Coron Artery Dis 15:259–264CrossRefPubMed Britten MB, Zeiher AM, Schächinger V (2004) Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome. Coron Artery Dis 15:259–264CrossRefPubMed
Metadaten
Titel
Association between serum total antioxidant status and coronary microvascular function in idiopathic dilated cardiomyopathy
verfasst von
M. Caliskan, MD
H. Gullu
D. Erdogan
M. Ozulku
S. Kulaksızoglu
O. Ciftci
H. Muderrisoglu
Publikationsdatum
01.05.2015
Verlag
Urban & Vogel
Erschienen in
Herz / Ausgabe 3/2015
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-013-4021-x

Weitere Artikel der Ausgabe 3/2015

Herz 3/2015 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.